Research Analyst at Tribeca Partners
Rob Brook is a Research Analyst at Tribeca Partners with a focus on fundamental company analysis within the healthcare sector. He has covered firms such as CytRx, notably engaging with company leadership on operational metrics and capital allocation strategies, but there is no publicly available record of broader company coverage or detailed third-party performance rankings. Brook joined Tribeca Partners in recent years; prior professional experience and a full career history are not disclosed in public sources. No information could be found to confirm securities licenses, FINRA registration, or notable industry recognitions.
Rob Brook from Tribeca Partners inquired about CytRx's current cash burn rate and the resulting cash runway, following the company's mention of a significant reduction in cash burn.
John Caloz, Chief Financial Officer, stated that the average monthly cash burn is approximately $850,000, excluding the recent Hercules loan payoff on August 1. He confirmed this provides a cash runway for the next 13 months.
Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.
Trusted by leading investment firms and analysts